Comirnaty is the first FDA-approved COVID-19 vaccine. Its full approval is expected to change the minds of many people who are skeptical to get vaccinated against the deadly disease. Businesses, schools, universities, and other organizations will now be more confident to implement vaccine mandates.
In a statement, Acting FDA Commissioner Janet Woodcock, M.D. said, “The FDA’s approval of this vaccine is a milestone as we continue to battle the COVID-19 pandemic. While this and other vaccines have met the FDA’s rigorous, scientific standards for emergency use authorization, as the first FDA-approved COVID-19 vaccine, the public can be very confident that this vaccine meets the high standards for safety, effectiveness, and manufacturing quality the FDA requires of an approved product.”
“While millions of people have already safely received COVID-19 vaccines, we recognize that for some, the FDA approval of a vaccine may now instill additional confidence to get vaccinated. Today’s milestone puts us one step closer to altering the course of this pandemic in the U.S.,” the FDA Acting Commissioner added.
